Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma

F. Morschhauser, J. Radford, A. van Hoof, U. Vitolo, P. Soubeyran, H. Tilly, P.C. Huijgens, A. Kolstad, F. d'Amore, D.M. Gonzalez, M. Petrini, C. Sebban, P.L. Zinzani, M.H. van Oers, W.L. van Putten, A. Bischof-Delaloye, A. Rohatiner, G. Salles, J. Kuhlmann, A. Hagenbeek

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)5156-5164
JournalJournal of Clinical Oncology
Issue number32
Publication statusPublished - 2008

Cite this